It has been demonstrated that a combined analysis of somatic RET and Ki-67 is useful for identifying patients with a more aggressive cancer, and their joint assessment could ameliorate the initial risk stratification of patients with sporadic MTC, and thus be of prognostic relevance [7]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.